Chlorpropamide
Back to searchMolecule Structure
Scientific Name
Chlorpropamide
Description of the Drug
Chlorpropamide is a sulfonylurea used in the treatment of non insulin dependent diabetes mellitus.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00672
http://www.drugbank.ca/drugs/DB00672
Brand Name(s)
Chlorpropamide, Diabemide, Diabinese, Glucamide, Glymese, Melitase
Company Owner(s)
Usl Pharma Inc, Dava Pharmaceuticals Inc, Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc, Sandoz Inc, Halsey Drug Co Inc, Pfizer Laboratories Div Pfizer Inc, Par Pharmaceutical Inc, Watson Laboratories Inc, Ani Pharmaceuticals Inc, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sulfonylurea receptor 1, Kir6.2 | PROTEIN COMPLEX | BLOCKER | CHEMBL2096972 |
Clinical Trial(s)
Unichem Links
| Atlas | chlorpropamide |
| SureChEMBL | SCHEMBL23947 |
| PharmGKB | PA448966 |
| Human Metabolome Database | HMDB0014810 |
| DrugBank | DB00672 |
| PubChem: Thomson Pharma | 15141440 |
| PubChem | 2727 |
| Mcule | MCULE-3261763364 |
| LINCS | LSM-6695 |
| Nikkaji | J3.944F |
| BindingDB | 50344965 |
| EPA CompTox Dashboard | DTXSID9020322 |
| DrugCentral | 622 |
| Brenda | 92903 |
| ChemicalBook | CB8677954 |
| Guide to Pharmacology | 6801 |
| rxnorm | CHLORPROPAMIDE |
| ChEBI | 3650 |
| ZINC | ZINC000001530599 |
